The synthetic histone-binding regulator protein PcTF activates interferon genes in breast cancer cells https://t.co/cWdQISrbDY #bmcsystbiol
KH: Triple-negative breast cancer cell line sensitive to PcTF #EpiBio2018 https://t.co/HpqrI6afE5 https://t.co/hCXQiy2nYb
RT @drkahaynes: It was great working with @sexchrlab to develop insights from our ‘omics data, from @biorxivpreprint pre-print to journal p…
RT @drkahaynes: It was great working with @sexchrlab to develop insights from our ‘omics data, from @biorxivpreprint pre-print to journal p…
RT @drkahaynes: It was great working with @sexchrlab to develop insights from our ‘omics data, from @biorxivpreprint pre-print to journal p…
Researchers demonstrate the potential for drugging histones in #breastcancer treatment. This opens a whole new area for drugs that sensitize breast cancer to the immune system. https://t.co/rgnGVArTTc #bmcsystbiol #epigenetics #transcriptomic
The synthetic histone-binding regulator protein PcTF activates interferon genes in breast can... https://t.co/2mK9LcTFCf